Studies on drug resistance in chronic lymphocytic leukemia
β Scribed by Robert Silber; Milan Potmesil; Bruce B. Bank
- Book ID
- 118372139
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 439 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0065-2571
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
25/27 patients are alive, while 2 patients died before D100. 15/24 patients reached metabolic remission. All of them are in complete remission at the time of evaluation after a median follow-up time of 515 (range 342 773) days. In 2/8 PETpositive patients rebiopsy proved progression or relapse. In 1
The treatment of any malignant disease requires appropriate criteria for diagnosis of the disease, appropriate methods for study, and techniques for evaluating response to treatment. In the past five years, there have been a number of proposed guidelines for studies in chronic lymphocytic leukemia (